FDA Regulatory Tuesday, October 20, 2026 0.00 Neutral

FDA Approves First Hep B Combo Treatment

The FDA approved Hibsago injection for treating chronic HBV in adults without cirrhosis when taken with existing antivirals.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed